ATE353327T1 - Thiophenverbindungen als arzneimittel - Google Patents

Thiophenverbindungen als arzneimittel

Info

Publication number
ATE353327T1
ATE353327T1 AT02756047T AT02756047T ATE353327T1 AT E353327 T1 ATE353327 T1 AT E353327T1 AT 02756047 T AT02756047 T AT 02756047T AT 02756047 T AT02756047 T AT 02756047T AT E353327 T1 ATE353327 T1 AT E353327T1
Authority
AT
Austria
Prior art keywords
sub
medicinal products
thiophene compounds
thiophene
compounds
Prior art date
Application number
AT02756047T
Other languages
English (en)
Inventor
David Griffiths
Craig Johnstone
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE353327T1 publication Critical patent/ATE353327T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT02756047T 2001-07-25 2002-07-19 Thiophenverbindungen als arzneimittel ATE353327T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102617A SE0102617D0 (sv) 2001-07-25 2001-07-25 Novel compounds

Publications (1)

Publication Number Publication Date
ATE353327T1 true ATE353327T1 (de) 2007-02-15

Family

ID=20284945

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02756047T ATE353327T1 (de) 2001-07-25 2002-07-19 Thiophenverbindungen als arzneimittel

Country Status (17)

Country Link
US (1) US7098240B2 (de)
EP (1) EP1421079B1 (de)
JP (2) JP2004536869A (de)
KR (1) KR20040018521A (de)
CN (1) CN1538968A (de)
AT (1) ATE353327T1 (de)
BR (1) BR0211472A (de)
CA (1) CA2454702A1 (de)
DE (1) DE60218048T2 (de)
ES (1) ES2280559T3 (de)
IL (1) IL160023A0 (de)
MX (1) MXPA04000755A (de)
NO (1) NO20040314L (de)
NZ (1) NZ530751A (de)
SE (1) SE0102617D0 (de)
WO (1) WO2003010163A1 (de)
ZA (1) ZA200400494B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003154D0 (en) * 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
SK288015B6 (sk) * 2001-06-11 2012-11-05 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
SE0102616D0 (sv) * 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
US7166639B2 (en) * 2001-10-04 2007-01-23 Smithkline Beecham Corporation NF-κB inhibitors
US7375131B2 (en) * 2002-06-06 2008-05-20 Smithklinebeecham Corp. NF-κB inhibitors
CN100413861C (zh) 2002-12-10 2008-08-27 维勒凯姆制药股份有限公司 用于治疗或预防黄病毒感染的化合物
SE0300092D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300091D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
US20050113566A1 (en) * 2003-04-25 2005-05-26 Player Mark R. Inhibitors of C-FMS kinase
US7427683B2 (en) * 2003-04-25 2008-09-23 Ortho-Mcneil Pharmaceutical, Inc. c-fms kinase inhibitors
MXPA05011503A (es) * 2003-04-25 2006-05-31 Johnson & Johnson Inhibidores de la c-fms cinasa.
US7790724B2 (en) 2003-04-25 2010-09-07 Janssen Pharmaceutica N.V. c-fms kinase inhibitors
EP1493739A1 (de) * 2003-07-03 2005-01-05 Warner-Lambert Company LLC Thiophenderivate von Aminosäuren, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
EP2305671A1 (de) * 2004-01-05 2011-04-06 AstraZeneca AB Thiophen- und Thiazolderivate als CHK1-Inhibitoren
TW200616967A (en) 2004-06-24 2006-06-01 Smithkline Beecham Corp Novel indazole carboxamides and their use
PE20060748A1 (es) 2004-09-21 2006-10-01 Smithkline Beecham Corp Derivados de indolcarboxamida como inhibidores de quinasa ikk2
AP2007004245A0 (en) 2005-05-13 2007-12-31 Virochem Pharma Inc Compounds and methods for the treatment or prevention of flavivirus infections
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
WO2007005534A2 (en) 2005-06-30 2007-01-11 Smithkline Beecham Corporation Chemical compounds
NZ576780A (en) 2006-11-15 2011-12-22 Virochem Pharma Inc Thiophene analogues for the treatment or prevention of flavivirus infections
CN101583598B (zh) * 2007-01-15 2012-09-12 参天制药株式会社 具有IκB激酶β抑制活性的新型吲哚衍生物
AR065804A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
RU2499592C2 (ru) 2008-04-21 2013-11-27 Отономи, Инк. Фармацевтическая композиция для лечения ушных заболеваний
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
CA2730281A1 (en) * 2008-07-14 2010-01-21 Santen Pharmaceutical Co., Ltd. Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group
CN102131774A (zh) 2008-08-25 2011-07-20 参天制药株式会社 含有脲基、氨基羰基及可以具有取代基的二环式基团作为取代基的新型吡咯衍生物
WO2010102968A1 (en) 2009-03-10 2010-09-16 Glaxo Group Limited Indole derivatives as ikk2 inhibitors
GB0913345D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab New combination 802
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
GB201021992D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab Compound
GB201021979D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab New compound
EP2520292A1 (de) 2011-05-06 2012-11-07 Helmholtz-Zentrum für Infektionsforschung GmbH Verwendung von Spirangienen zur Behandlung oder Prävention von IL-8- oder IL-6-vermittelten Erkrankungen
KR20190024983A (ko) 2016-06-29 2019-03-08 오토노미, 인코포레이티드 트리글리세라이드 귀 제제 및 이의 용도
CN107739370B (zh) * 2017-10-26 2021-03-30 中国药科大学 吡咯酮类brd4蛋白抑制剂的制备方法以及用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468012A (en) * 1973-08-09 1977-03-23 Beecham Group Ltd 2-amino-3-carboxy-thiophene derivatives
DE3529247A1 (de) 1985-05-17 1986-11-20 Bayer Ag, 5090 Leverkusen Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
AU3044197A (en) 1996-07-11 1998-02-09 Pfizer Inc. Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
PT853083E (pt) * 1997-01-06 2001-12-28 Pfizer Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica
US6809088B2 (en) * 1997-03-24 2004-10-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
US6037340A (en) 1997-05-28 2000-03-14 Cadus Pharmaceutical Corporation Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds
DE19744026A1 (de) 1997-10-06 1999-04-08 Hoechst Marion Roussel De Gmbh Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
AU2713799A (en) 1998-03-12 1999-09-27 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
HN2000000051A (es) * 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
CN100355751C (zh) * 2000-03-29 2007-12-19 西克拉塞尔有限公司 2－取代的4－杂芳基－嘧啶、其组合物及其用途
US6414013B1 (en) 2000-06-19 2002-07-02 Pharmacia & Upjohn S.P.A. Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
WO2002030353A2 (en) 2000-10-12 2002-04-18 Smithkline Beecham Corporation NF-λB INHIBITORS

Also Published As

Publication number Publication date
US7098240B2 (en) 2006-08-29
NZ530751A (en) 2005-09-30
CN1538968A (zh) 2004-10-20
KR20040018521A (ko) 2004-03-03
US20040235821A1 (en) 2004-11-25
ES2280559T3 (es) 2007-09-16
MXPA04000755A (es) 2004-04-20
JP2010111683A (ja) 2010-05-20
NO20040314L (no) 2004-03-25
DE60218048D1 (de) 2007-03-22
SE0102617D0 (sv) 2001-07-25
EP1421079A1 (de) 2004-05-26
IL160023A0 (en) 2004-06-20
DE60218048T2 (de) 2007-08-09
WO2003010163A1 (en) 2003-02-06
CA2454702A1 (en) 2003-02-06
BR0211472A (pt) 2004-11-09
JP2004536869A (ja) 2004-12-09
ZA200400494B (en) 2005-04-22
EP1421079B1 (de) 2007-02-07

Similar Documents

Publication Publication Date Title
ATE353327T1 (de) Thiophenverbindungen als arzneimittel
MXPA04000756A (es) Nuevos compuestos.
GB0003154D0 (en) Novel compounds
SE0102439D0 (sv) New compounds
PT1263725E (pt) Novos compostos
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
HUP0401783A2 (hu) 3,4-Diszubsztituált ciklobutén-1,2-dionok mint CXC-kemokin receptor ligandumok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
HRP20040317A2 (en) 1,8-naphthyridine derivatives as antidiabetics
HUP0400998A3 (en) Novel compounds of anti-inflammatory, immunomodulatory and anti-proliferatory effect, process for their preparation and pharmaceutical compositions containing them
SE9902987D0 (sv) Novel compounds
HK1082250A1 (en) Thiophene carboxamides as inhibitors of the enzymeikk-2
SE0302116D0 (sv) Novel compounds
SE0300092D0 (sv) Novel compounds
SE9902765D0 (sv) Novel compounds
SE0101322D0 (sv) Novel compounds
IL157653A0 (en) Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
ATE400563T1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
DK1631574T3 (da) Colchicosidanaloge
EE200300548A (et) Uudsed 5-tio-ß-D-ksülopüranosiidi derivaadid, nende valmistamise meetod, neid sisaldavad farmatseutilised kompositsioonid ja nende terapeutiline kasutamine
ATE298564T1 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten und einen netzmittel
MY135855A (en) "pyrrolopyrimidinone derivatives, process of preparation and use"
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties